Editor's Choice
Latest Update
EINDHOVEN, Netherlands, March 28, 2023 /PRNewswire/ -- Sirius Medical,...
> read more
Editor's Choice
Acutis Diagnostics Leverages SOPHiA GENETICS Technology to Create New Next Generation Sequencing Test
BOSTON & LAUSANNE, Switzerland--(BUSINESS WIRE)--SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine,...
Propanc Biopharma Announces That PRP Suppresses TGF-β Pathway & Tumor Microenvironment in Pancreatic Cancer
MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for...
Surmodics Provides Regulatory Update on its Strategy to Submit an Amended Premarket Approval Application for the SurVeil™ Drug-Coated Balloon
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today...
The Department of Health - Abu Dhabi recognises Abu Dhabi Stem Cells Center (ADSCC) as a centre of excellence in hematopoietic stem cell transplantation
In line with its constant efforts to consolidate Abu Dhabi's position as a leading destination for healthcare, and to enhance the competitiveness and effectiveness of the...
Seegene declares to share Syndromic PCR technologies to prevent future pandemics
Seegene Inc. a leading South Korean company providing a total solution for PCR molecular diagnostics, declared the commencement of sharing its syndromic PCR technologies all over...
MEDICA 2023 + COMPAMED 2023 on schedule - hot phase of registration and theme planning running with momentum
With a notable increase in the number of exhibitors and a strong boost in the amount of visitors, in November 2022, the internationally leading trade fairs for the medical...
DermaSensor Unveils Study Results Demonstrating Ability to Detect Skin Cancer With Device Granted FDA Breakthrough Designation
MIAMI--(BUSINESS WIRE)--DermaSensor Inc., a health technology company equipping primary care physicians (PCPs) with a non-invasive device for use in evaluation of suspicious skin...
AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease
VANCOUVER, British Columbia & LONDON--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) and RQ Bio announced today that they have entered into a strategic collaboration to identify...
Cidara Therapeutics and Melinta Therapeutics Announce FDA Approval of REZZAYO™ (rezafungin for injection) for the Treatment of Candidemia and Invasive Candidiasis
SAN DIEGO & PARSIPPANY, N.J.--(BUSINESS WIRE)--Cidara Therapeutics, Inc. (Nasdaq: CDTX) and Melinta Therapeutics, LLC today announced that the U.S. Food and Drug Administration...
STIMVIA Announces Promising Results from Clinical Study Regarding Overactive Bladder
PRAGUE, March 21, 2023 /PRNewswire/ -- STIMVIA a pioneer medical technology company focused on the development and commercialization of novel non-invasive neuromodulation for...
Launching an Innovative Product, PlaClin-M, for Safe Environments in the Pandemic Era.
SEOUL, South Korea, March 23, 2023 /PRNewswire/ -- CodeSteri, a leading provider of disinfection solutions, is proud to announce the launch of PlaClin-M, a revolutionary device...
Merck Provides Update from Open-Label Arm of Phase 2 KeyVibe-002 Trial Evaluating MK-7684A, a Coformulation of Vibostolimab and Pembrolizumab, in Previously Treated Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC)
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today provided an update on the open-label arm of the non-registrational Phase...
Prestige Biopharma Receives FDA Fast Track Designation for PBP1510 in the Treatment of Pancreatic Cancer
SINGAPORE--(BUSINESS WIRE)--Prestige Biopharma has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for PBP1510 (International Non-proprietary...
Kerecis, the Medical-Fish-Skin company, named one of Europe’s fastest growing companies by Financial Times
Kerecis® has been included in the FT1000 list of Europe’s fastest growing companies. The medical-fish-skin company ranked fifth in the healthcare and life sciences...
LEO Pharma presents late-breaking positive Phase 2a efficacy and safety results of LEO 138559 in moderate-to-severe atopic dermatitis at the 2023 AAD Annual Meeting
BALLERUP, Denmark, MARCH 18, 2023 – LEO Pharma A/S, a global leader in medical dermatology, today announced that a Phase 2a trial evaluating the efficacy and safety of...
Active Wound Care Market To Develop Strongly And Cross USD 1,916 million by 2032
New York, March 13, 2023 (GLOBE NEWSWIRE) -- According to Market.us, the global active wound care market was valued at around USD 1,137 million in 2022 and is expected to...
Altoida announces upcoming poster presentations at AD/PD 2023
Altoida, Inc., a precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality ,announced two...
Droplet Biosciences Announces Lymph Diagnostic Platform to Help Prevent Cancer Recurrence
Droplet Biosciences announced an $8 million seed investment to establish proof of concept for the company’s technology. While the lymphatic system’s critical role in metastasis has...
The Egyptian Authority for Unified Procurement (UPA) and the Arab Hospital Federation (AHF) signed a protocol on cooperation to consolidate the role of the Africa Health ExCon
The Egyptian Authority for Unified Procurement (UPA) and Arab Hospital Federation (AHF) on Tuesday signed a Protocol of Cooperation to enhance the role of the Africa Health ExCon-2023...
